Medijski sadržaj
- Tweetovi
- Tweetovi i odgovori
- Medijski sadržaj, trenutna stranica.
-
BREAKING NEWS: American
#lifeexpectancy rises for the first time in four years due to improvements in#cancer mortality rates and decline in death from opioid overdose. https://nyti.ms/2OcctAz#precisionmedicine#PMWC20pic.twitter.com/iBn68XMuGs
-
A study found that the implementation of
#machinelearning into clinical#breastMRI can provide accurate decision rules for the management of suspicious breast masses. http://bit.ly/2S3uZfG@PLOSONE@UCSDMedSchool#decisionsupport#precisionmedicine#PMWC20pic.twitter.com/fpnEUBESWR
-
The first cost-effectiveness analysis of CAR-T tisagenlecleucel compared with current standard care for pediatric patients with acute lymphoblastic leukemia (ALL) using a constructed population-based control arm. http://bit.ly/2uVOQFu
@JAMAOnc@CUPharmacy#leukemia#PMWC20pic.twitter.com/xDGZOSIDbw
-
The next generation of
#proteomics-based methods will complement current methods, providing an insight into health and disease mechanisms. http://bit.ly/36LeQkm@sciencemagazine@Agilent#singlecellanalysis#precisionmedicine#PMWC20pic.twitter.com/F4xduQYdRB
-
CMS MolDx finalized coverage for
#liquidbiopsies. Initially, the policy will only cover the Guardant360 assay if the patient has a recurrent, relapsed, refractory, metastatic, or advanced solid tumor that didn't originate from the CNS. https://go.cms.gov/2Ofq4qN@CMSGov#cancerpic.twitter.com/dZ4Ce03sVT
-
Using checkpoint blockade therapies in the neoadjuvant setting presents a potential solution for de novo or acquired resistance in the adjuvant setting. http://bit.ly/318LtqQ
@sciencemagazine@parkerici#immunotherapy#cancer#precisionmedicine#PMWC20pic.twitter.com/cyWnp8Viqh
-
Thank you Dr.
@MichaelPellini for chairing a panel on "Implementing Precision Medicine in Hospitals" and for raising the very important Q: "Are we getting the medicines, the diagnostics, the interventions to those individuals that never make it to an academic medical center?"pic.twitter.com/h87nckLX60
-
Molecular profile that includes data about the microbiome and genome, information about metabolites and proteins, and physiological measurements could reduce drug development cost and time. https://go.nature.com/38QuOuX
@daytwohealth@segal_eran@WeizmannScience#PMWC20pic.twitter.com/84Fea6n659
-
Study of rare variants in the exomes of more than 70,000 individuals. Justin Kao led a panel on scalable return of genomics, at the PMWC 2020 Silicon Valley.
@JustinKaoHelix@my_Helix#genomics#bioinfomarics#precisionmedicine@nresearchnews@uk_biobank@HealthyNV#PMWC20pic.twitter.com/rX6U1rLeex
-
#AI algorithms must show efficacy in robust clinical trials and in the real world to move into the next phase of clinical implementation. http://bit.ly/311dukl Dr.@sharmilamajumda led a panel discussing those issues on Friday at#PMWC20.@UCSFPrecision@UCSF@LancetDigitalHpic.twitter.com/6OYAXULGpv
-
BREAKING NEWS: U.S. FDA released six new policies on gene therapy development aimed at encouraging pharmaceutical companies to bring new therapies to market. http://bit.ly/2U3tH6Y
@US_FDA#genetherapy#drugregulation#precisionmedicinepic.twitter.com/03cmUY02Rt
-
BREAKING NEWS: CMS expands coverage of Next Generation Sequencing as a diagnostic tool for patients with breast and ovarian cancer. CMS also gave Medicare contractors more leeway to use NGS for other cancers as well. https://go.cms.gov/2O7ICcG
@CMSGov#genomics#NGS#breastcancerpic.twitter.com/xfcol1Qlos
-
For those that attended Dr. Raj Puri's session on Friday at the PMWC 2020 Silicon Valley, you can register for the FDA Individualized Therapeutics Workshop on March 3rd at: http://bit.ly/2O4X30U
@US_FDA#genomics#rarediseases#precisionmedicine#PMWC20pic.twitter.com/tCrrY5fo45
-
A prospective study of 1,190 patients found that by integrating whole-genome sequencing with advanced imaging and blood metabolites, researchers identified clinically significant findings associated with age-related chronic conditions. http://bit.ly/30W5S2u
#PMWC20pic.twitter.com/wPLplecsQG
-
Venture capital and health system investors are bullish on digital health, patient engagement and genomics startups. As a result, among the most-funded startups are 23andMe with nearly $800M in funding, and
@Tempus with $520 million.#VC#digitalhealth#AI#genomics#PMWC20pic.twitter.com/qVVYnOz3IO
-
You no longer can sit on the fence! The
@WSJ reports that rapid digitization of health records in recent years and privacy laws enabling companies to swap patient data, with potential for groundbreaking discoveries and lucrative products. https://on.wsj.com/2NMwGgi@wsj#EHRpic.twitter.com/M0mxaOkgXn
-
New study reveals that the presence in tumours of two key immune components — B cells and tertiary lymphoid structures — is associated with favourable outcomes when individuals undergo immunotherapy. Hear more at
#PMWC20. https://go.nature.com/37avcnr@nresearchnews@MDAndersonNewspic.twitter.com/IvzLwQXmws
-
@QuanterixSimoa CEO Kevin@KevinHrusovsky reported at JPM 2020 that the firm sold 55 of its HD-X analyzers, adding to the 202 installed base for its HD-1 instrument. Hear more from Hrusovsky at#PMWC20. http://bit.ly/2TLEd2N#biomarker#precisionmedicine#JPM20pic.twitter.com/QOm6hRqBOC
-
@Invitae's CEO, Sean George reported at JPM 2020 that the firm's volume of accessioned tests in 2019 grew to greater than 482,000, an impressive increase of 60% over the 303,000 tests in 2018. Hear from Tina Hambuch and other Invitae speakers at#PMWC20. http://bit.ly/2RyTyAP pic.twitter.com/3sh2Zei96M
-
"When we can bring together the best of the drug and diagnostic development world with the best and the brightest in the machine learning/AI world, then we truly work together as a team,"
@MichaelPellini,#PMWC20 https://lnkd.in/g-sBEVT#genomics#ai#VC#precisiononcologypic.twitter.com/9TxldGkfyX
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.